Candel Therapeutics, Inc. · NASDAQ:CADL
Candel Therapeutics, Inc. shareholders
As of Jun 30, 2026, 134 institutions reported holding Candel Therapeutics, Inc., 65.9% of its shares. Largest: Fidelity, Rtw Investments, LP and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Candel Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Fidelity | 11M | 14.4% | +3,518 | Aug 13, 2026 |
| Rtw Investments, LP | 6.42M | 8.4% | no change | Aug 14, 2026 |
| BlackRock | 4.97M | 6.5% | +1.86M | Aug 7, 2026 |
| Vanguard | 3.58M | 4.7% | +555K | Aug 13, 2026 |
| State Street | 3.55M | 4.6% | +2.73M | Aug 7, 2026 |
| Acorn Capital Advisors, LLC | 3.5M | 4.6% | no change | Aug 14, 2026 |
| Portolan Capital Management, LLC | 3.49M | 4.6% | +596K | Aug 14, 2026 |
| Saturn V Capital Management LP | 3.3M | 4.3% | +407K | Aug 14, 2026 |
| Geode Capital | 1.57M | 2.1% | +536K | Aug 12, 2026 |
| Millennium | 1.09M | 1.4% | +33,819 | Aug 14, 2026 |